Invention Grant
US08703139B2 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases
失效
针对黑皮质素-4受体的单克隆抗体及其结合片段及其在治疗恶病质和相关病症和疾病中的应用
- Patent Title: Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases
- Patent Title (中): 针对黑皮质素-4受体的单克隆抗体及其结合片段及其在治疗恶病质和相关病症和疾病中的应用
-
Application No.: US13560638Application Date: 2012-07-27
-
Publication No.: US08703139B2Publication Date: 2014-04-22
- Inventor: Karl Hofbauer , Jean Christophe Peter
- Applicant: Karl Hofbauer , Jean Christophe Peter
- Applicant Address: CH Basel
- Assignee: Universitaet Basel
- Current Assignee: Universitaet Basel
- Current Assignee Address: CH Basel
- Agency: Agris & von Natzmer LLP
- Agent Joyce von Natzmer
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
Disclosed are monoclonal antibodies, binding fragments, and derivatives thereof directed to the human melanocortin-4 receptor, as well as pharmaceutical compositions including the same, the therapeutic uses, including methods for treating cachexia and related conditions and diseases, using such monoclonal antibodies, binding fragments, derivatives, and pharmaceutical compositions.
Public/Granted literature
Information query
